General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Merck & Co., Inc.(MODEST), BeiGene(MODEST), Bristol Myer Squibb(SIGNIFICANT), Exelixis(MODEST) RESEARCH/RESEARCH GRANTS: Amgen Inc.(SIGNIFICANT), Bristol Myer Squibb(SIGNIFICANT), Agios(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Sanofi-Aventis(SIGNIFICANT), BeiGene(SIGNIFICANT), Array BioPharma(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Macrogenics(SIGNIFICANT)

View Full Disclosure